{
  "actions": [
    {
      "acted_at": "2016-05-24", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-05-24", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5314-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "bioguide_id": "C001103", 
      "district": "1", 
      "name": "Carter, Earl L. \"Buddy\"", 
      "original_cosponsor": true, 
      "sponsored_at": "2016-05-24", 
      "state": "GA", 
      "thomas_id": "02236", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-05-24", 
  "number": "5314", 
  "official_title": "To provide for the development and dissemination of programs and materials for training pharmacists, health care providers, and patients on the circumstances under which a pharmacist may decline to fill a prescription for a controlled substance because the pharmacist suspects the prescription is fraudulent, forged, or otherwise indicative of abuse or diversion, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Empowering Pharmacists in the Fight Against Opioid Abuse Act", 
  "sponsor": {
    "bioguide_id": "D000623", 
    "district": "11", 
    "name": "DeSaulnier, Mark", 
    "state": "CA", 
    "thomas_id": "02227", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-05-24", 
  "subjects": [
    "Crime and law enforcement"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2016-05-24T04:00:00Z", 
    "text": "Empowering Pharmacists in the Fight Against Opioid Abuse Act\n\nThis bill requires the Drug Enforcement Administration (DEA) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.\n\nThe DEA must seek input from relevant stakeholders."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Empowering Pharmacists in the Fight Against Opioid Abuse Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To provide for the development and dissemination of programs and materials for training pharmacists, health care providers, and patients on the circumstances under which a pharmacist may decline to fill a prescription for a controlled substance because the pharmacist suspects the prescription is fraudulent, forged, or otherwise indicative of abuse or diversion, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Empowering Pharmacists in the Fight Against Opioid Abuse Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:29:09Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr5314.xml"
}